Jose Rodriguez-Morato
Overview
Explore the profile of Jose Rodriguez-Morato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calles A, Navarro A, Doger Speville Uribe B, Doger de Speville Uribe B, Colome E, de Miguel M, et al.
J Thorac Oncol
. 2025 Feb;
PMID: 39938593
Introduction: SCLC has limited second-line treatment options after chemotherapy. We assessed the efficacy and safety of lurbinectedin combined with pembrolizumab in relapsed SCLC patients who had not received prior immunotherapy,...
2.
Cortes A, Lopez-Miranda E, Fernandez-Ortega A, Caranana V, Servitja S, Urruticoechea A, et al.
Breast
. 2024 Nov;
78:103834.
PMID: 39520738
Purpose: To evaluate olaparib in advanced triple negative breast cancer (TNBC) patients with homologous recombination deficiency (HRD) and no germline BRCA1/2 mutations (gBRCA1/2mut). Methods: NOBROLA (NCT03367689) is a single-arm, open-label,...
3.
Serreli G, Boronat A, de la Torre R, Rodriguez-Morato J, Deiana M
Cells
. 2024 Sep;
13(18.
PMID: 39329739
Extra virgin olive oil (EVOO) represents a significant source of monounsaturated fatty acids (MUFA) and vitamin E, but it is also considered a functional food, due to the content of...
4.
Sebri V, Marzorati C, Dorangricchia P, Monzani D, Grasso R, Prelaj A, et al.
Cancer Med
. 2024 May;
13(9):e7159.
PMID: 38741546
Introduction: To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient...
5.
Perez-Garcia J, Cortes J, Ruiz-Borrego M, Colleoni M, Stradella A, Bermejo B, et al.
Lancet
. 2024 Apr;
403(10437):1649-1659.
PMID: 38582092
Background: PHERGain was designed to assess the feasibility, safety, and efficacy of a chemotherapy-free treatment based on a dual human epidermal growth factor receptor 2 (HER2) blockade with trastuzumab and...
6.
Gion M, Garcia-Mosquera J, Perez-Garcia J, Peg V, Ruiz-Borrego M, Stradella A, et al.
Breast Cancer Res Treat
. 2024 Mar;
205(3):589-598.
PMID: 38456970
Purpose: The prognostic and predictive role of trophoblast cell-surface antigen-2 (Trop-2) overexpression in human epidermal growth factor receptor 2-positive (HER2-positive) breast cancer is currently unknown. We retrospectively analyzed Trop-2 expression...
7.
Bentanachs R, Blanco L, Montesinos M, Sala-Vila A, Lazaro I, Rodriguez-Morato J, et al.
Nutrients
. 2023 Sep;
15(18).
PMID: 37764693
Non-alcoholic fatty liver disease is a sexual dimorphic disease, with adipose tissue playing an essential role. Our previous work showed that female rats fed a high-fat high-fructose diet devoid of...
8.
Boronat A, Serreli G, Rodriguez-Morato J, Deiana M, de la Torre R
Antioxidants (Basel)
. 2023 Jul;
12(7).
PMID: 37508010
Epidemiological studies have shown that consuming olive oil rich in phenolic bioactive compounds is associated with a lower risk of neurodegenerative diseases and better cognitive performance in aged populations. Since...
9.
Velazquez A, Bentanachs R, Sala-Vila A, Lazaro I, Rodriguez-Morato J, Sanchez R, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884822
Bempedoic acid (BemA) is an ATP-citrate lyase (ACLY) inhibitor used to treat hypercholesterolemia. We studied the anti-steatotic effect of BemA, and the mechanisms involved, in a model of fatty liver...
10.
Gomez-Gomez A, Rodriguez-Morato J, Haro N, Marin-Corral J, Masclans J, Pozo O
Anal Chim Acta
. 2022 Feb;
1196:339405.
PMID: 35151400
Metabolomics (both targeted and untargeted) has become the gold standard in biomarker discovery. Whereas targeted approaches only provide information for the selected markers, thus hampering the determination of out-of-the-box markers,...